Of 1,000 births worldwide, in one embryo the neural tube will fail to close properly 28 days after conception, resulting in some form of neural tube defect (NTD). Failed closure at the cranial end, known as anencephaly, is a lethal condition, whereas failed closure at the caudal end usually results in a myelomeningocele. NTDs are the most common debilitating birth defect. Familial studies indicate a significant genetic component to NTDs, with a 40-fold increase in risk in first-degree relatives ([@b6-ehp0114-001547]). Myriad environmental exposures have been implicated in the development of NTDs; most notably, a significant decrease in risk can be achieved by maternal folic acid supplementation before conception.

The mechanism by which dietary folate supplementation prevents NTDs is poorly understood ([@b19-ehp0114-001547]). Folic acid derivatives are essential for the synthesis of DNA, cell division, tissue growth, and DNA methylation ([@b18-ehp0114-001547]). Methylation enables proper gene expression and chromosome structure maintenance, both of which are critical in the developing embryo ([@b23-ehp0114-001547]). The folate and methionine cycles are linked by the conversion of homocysteine to methionine ([Figure 1](#f1-ehp0114-001547){ref-type="fig"}). In the absence of food frequency data, maternal vitamin supplementation can also serve as a proxy for overall health because of the positive correlation between supplement intake, diet, and a healthy lifestyle ([@b29-ehp0114-001547]). Vitamin supplementation is an important cofactor to consider when studying nutritionally related genes.

Animal models demonstrate that periconceptional folate supplementation protects against congenital defects in the face, neural tube, and conotruncal region of the heart. Low folate could directly limit its availability to cells or indirectly disrupt methionine metabolism, thereby increasing homocysteine in the maternal serum ([@b26-ehp0114-001547]). Either mechanism implicates folate receptor and methionine--homocysteine regulatory genes.

Folate enters cells by folate receptor 1 \[*FOLR1*; GenBank accession no. NM_016725 (<http://www.ncbi.nih.gov/GenBank>)\] and folate receptor 2 (*FOLR2*; GenBank accession no. NM_000803) or carrier-mediated internalization by solute carrier family 19 member 1(*SLC19A1*; GenBank accession no. U15939), also known as reduced folate carrier protein 1. Transcobalamin II (*TCN2*; GenBank accession no. NM_000355) imports vitamin B~12~, cobalamin, a cofactor for another folate enzyme, 5-methyltetrahydrofolate-homocys-teine methyltransferase (*MTR*; GenBank accession no. NM_000254).The reactions within the folate metabolism cycle can be very complex, with methylenetetrahydrofolate dehydrogenase 1 (*MTHFD1*; GenBank accession no. J04031), serine hydroxymethyl-tranferase 1 (*SHMT1*; GenBank accession no. NM_004169), and 5,10-methylenetetrahy-drofolate reductase (*MTHFR* ; GenBank accession no. NM_005957) being widely studied in the NTD literature.

*MTHFR* rs1801133 is the most frequently investigated polymorphism in NTDs with conflicting results in different populations: Dutch and Irish populations associate the TT allele with risk ([@b28-ehp0114-001547]; [@b34-ehp0114-001547]), whereas a protective effect is seen in Italians ([@b5-ehp0114-001547]) and other populations have no evidence of association ([@b10-ehp0114-001547]; [@b25-ehp0114-001547]; [@b32-ehp0114-001547]). This polymorphism also has a confirmed role heart disease ([@b9-ehp0114-001547]).

Homocysteine can accumulate from low dietary folate, cobalamin, and/or genetic factors ([@b18-ehp0114-001547]; [@b22-ehp0114-001547]) and is elevated in some NTD mothers ([@b16-ehp0114-001547]; [@b31-ehp0114-001547]). Homocysteine itself may be teratogenic ([@b27-ehp0114-001547]) or impair substrates for methylation reactions ([@b7-ehp0114-001547]). Enzymes that degrade homocysteine regulate homocysteine levels; for example, MTR converts homocysteine to methionine and folate to tetrahydrofolate ([@b33-ehp0114-001547]). 5-Methyltetrahydrofolate-homocysteine methyltransferase reductase (*MTRR*; GenBank accession no. AF025794) maintains MTR in its active state. Betaine-homocysteine methyltransferase (*BHMT*; GenBank accession no. BC012616) remethylates homocysteine to methionine with a betaine cofactor ([@b17-ehp0114-001547]). Cystathionine-betasynthase (*CBS*; GenBank accession no. NM_000071) controls homocysteine levels by degrading homocysteine into cystathionine ([@b18-ehp0114-001547]).

Detecting moderate effects of multiple folate genes will be particularly difficult if they are interactive or additive with environmental impacts ([@b18-ehp0114-001547]). This complex pathway has several known metabolic interactions, such as MTRR maintaining MTR in an active state. Previous studies found an association of *MTHFR* and *MTRR* ([@b11-ehp0114-001547]; [@b40-ehp0114-001547]) plus *CBS* and the *MTHFR* thermolabile variant with NTDs ([@b2-ehp0114-001547]; [@b22-ehp0114-001547]; [@b30-ehp0114-001547]).

Thus, genes involved in folate metabolism are compelling candidates for NTDs, from both a genetic and an environmental perspective.

Material and Methods
====================

Sample population
-----------------

All polymorphisms were genotyped in 304 families with at least one individual affected with an NTD and their first-degree relatives when available. These families represent 240 complete trios and 64 families with only one parent, whereas 16 of these families had two or more affected individuals. Cases with lumbosacral myelomeningocele were classified as affected in the narrow diagnostic criteria, and any level NTD was affected in the broad criteria. These Caucasian families were collected from 13 sites across the United States through myelodysplasia clinics, neuro-surgical referrals, our study website, and word of mouth. The family-based study design is robust to potential population stratification and particularly useful when sampling over such a wide geographic area. Most affected individuals were ascertained as children (average age at sample, 14.3 years) with no sex differences. In 74% of NTD case mothers, extensive environmental exposure interviews were conducted, including pre- and post-conceptional vitamin use. [Table 1](#t1-ehp0114-001547){ref-type="table"} outlines the sample sizes subdivided by diagnostic criteria and maternal folate supplementation. This study was approved by the Duke University Medical Center Institutional Review Board, and all data and samples were collected after informed consent of subjects.

SNP genotyping
--------------

Eleven genes of the folate pathway are included in our study and were selected from previously published NTD research ([Table 2](#t2-ehp0114-001547){ref-type="table"}). Three genes that degrade homocysteine (*MTR*, *BHMT*, and *CBS*) were more thoroughly genotyped based on HapMap Release 19 ([@b12-ehp0114-001547]) tagging single nucleotide polymorphisms (SNPs) and location in the gene ([Figure 2](#f2-ehp0114-001547){ref-type="fig"}). All but two genetic variants were genotyped by commercially available TaqMan allelic discrimination assays (Assay-on-Demand and Assay-by-Design, Applied Biosystems, Foster City, CA). Previously published poly-merase chain reaction (PCR) primers for a 68-bp insertion in *CBS* exon 8 ([@b18-ehp0114-001547]) produced results that did not pass the quality control measures outlined below. Sequencing of the insertion showed a tandem duplication such that the forward primer hybridized before and within the insertion. We used a forward primer 58 bp further upstream of the insertion producing 242 or 310 bases fragments (forward, 5′-CGGCGGTATTG-GCCACTC-3′; reverse, 5′ GGCCGGGC-TCTGGACTC-3′). The *SLC19A1* SNP rs1051266 was genotyped by melting curve analysis in the MGB Eclipse Probe System ([@b4-ehp0114-001547]). All PCR amplification used the GeneAmp PCR system 9700 thermo-cyclers (Applied Biosystems) according to assay specifications. Fluorescence was detected with the ABI Prism 7900HT Sequence Detection System and analyzed with ABI Prism Sequence Detection System software (version 2.0; Applied Biosystems). Quality control measures consisted of two reference samples from the Centre d'Etude du Polymorphisme Humain in Paris, France, and 24 duplicated samples per 384-well plate plus blinded from laboratory technicians. These 26 samples had to match completely, and at least 90% of all samples had to be successfully genotyped for the polymorphism to pass quality control. Genotypes were also checked for Mendelian inconsistencies within families.

Statistical analysis
--------------------

Family-based association analysis was performed using the pedigree disequilibrium test (PDT) ([@b15-ehp0114-001547]) and association in the presence of linkage (APL) test ([@b14-ehp0114-001547]). Because of the mixed family types and incomplete sampling in our data set, PDT will take advantage of multiplex families, whereas APL performs better with missing data. These tests were performed on all SNPs for the narrow and broad phenotypes in the overall data set as well as those subdivided by maternal folate supplementation, *BHMT* allele transmission, and *MTHFR* allele transmission. All SNPs were checked for Hardy-Weinberg equilibrium (HWE) separately in unrelated affected individuals and unaffected relatives in the complete data set using genetic data analysis ([@b38-ehp0114-001547]). The reported *p*-values have not been corrected for multiple testing, but a strict correction is not critical given the biological plausibility implicating these genes in NTDs. Linkage disequilibrium (LD) between the SNPs in the same gene was calculated using the Graphical Overview of Linkage Disequilibrium (GOLD) software package ([@b1-ehp0114-001547]).

Results
=======

Single gene associations with an environmental stratification
-------------------------------------------------------------

The initial analysis of the entire data set for 28 SNPs in 11 genes ([Table 3](#t3-ehp0114-001547){ref-type="table"}) found associations: *BHMT* rs3733890 (narrow PDT *p* = 0.023, narrow APL *p* = 0.058, broad PDT *p* = 0.025, broad APL *p* = 0.035) and *BHMT* rs558133 (broad PDT *p* = 0.025, broad APL *p* = 0.061). All SNPs were in HWE except the *MTHFD1* SNP rs2236225 in affected individuals only (data not shown). When subdivided by case mothers' dietary supplementation with folate 3 months before conception, the *BHMT* associations were significant only in the supplemented group: rs3733890 (narrow PDT *p* = 0.027, narrow APL *p* = 0.055, broad PDT *p* = 0.016, broad APL *p* = 0.027) and rs558133 (narrow PDT *p* = 0.036, broad PDT *p* = 0.012).

When all SNPs were analyzed in the stratified data set, two other genes had significant associations ([Table 3](#t3-ehp0114-001547){ref-type="table"}). *MTHFR* rs1801133 was associated by APL with the narrow phenotype in families that did not supplement (*p* = 0.046). Also in the nonsupplementing families, *CBS* was associated by PDT with the broad phenotype in rs234715 (*p* = 0.015) and rs4920037 (*p* = 0.037) and SNPs in *MTR* showed significance: rs1092535 (narrow PDT *p* = 0.066, narrow APL *p* = 0.031, broad PDT *p* = 0.040, broad APL *p* = 0.04) and rs4659743 (narrow APL *p* = 0.013, broad PDT *p* = 0.041, broad APL *p* = 0.010). Despite being 96.6 kb apart, high LD (*D*′ = 0.973, *r*^2^ = 0.946) throughout *MTR* could account for both SNPs' associations ([Table 4](#t4-ehp0114-001547){ref-type="table"}).

Stratifying by other genes
--------------------------

In complex conditions like NTDs, multiple genes are likely contributing to folate-related risk. To evaluate multigenic effects, families were grouped by preferential transmission of an allele to affected offspring and reevaluated for all other SNPs. For *BHMT* rs373389, 79 families preferentially transmitted the G allele, 59 transmitted the A allele, 149 transmitted both equally or had homozygous parents, whereas 17 could not be determined and were not included in the analysis ([Table 5](#t5-ehp0114-001547){ref-type="table"}). When the G allele was preferentially transmitted, the *CBS* insertion was significant by PDT (*p* = 0.033 for both diagnostic groups), whereas two SNPs were significant by APL: *SHMT* rs1979277 (*p* = 0.042 narrow, *p* = 0.020 broad) and *MTR* rs4659743 (*p* = 0.049 narrow, *p* = 0.015 broad). When segregating the A allele, *MTHFD1* rs2236225 was significant by PDT in the broad phenotypic group (*p* = 0.016). Other SNPs in *BHMT* were significant in the stratified groups due to inter-marker LD ([Table 4](#t4-ehp0114-001547){ref-type="table"}).

We performed a similar analysis stratifying by transmission of the *MTHFR* rs1801133 thermolabile T allele ([Table 6](#t6-ehp0114-001547){ref-type="table"}). Sixty-eight families were grouped for the T allele; 90 families were grouped for the C allele; 134 families did not preferentially transmit either allele; and 12 were excluded. With overtransmission of the T allele, *BHMT* rs3733890 is more significant than in any prior analysis (narrow PDT *p* = 0.007, narrow APL *p* = 0.027, broad PDT *p* = 0.010, broad APL *p* = 0.047), and *TCN2* rs1801198 was associated by PDT with the broad phenotype (*p* = 0.045). For the C allele subset, rs1801394 in *MTRR* was significant by APL in the broad group (*p* = 0.048). When neither allele was preferred, the *SHMT* SNP is significant by PDT (*p* = 0.050 for narrow, 0.037 for broad).

Discussion
==========

BHMT contributes to the risk of NTDs
------------------------------------

*BHMT* is significantly associated with NTDs in our sample set, particularly when mothers were receiving preconceptional folate or parents preferentially transmitted the *MTHFR* rs1801133 T allele. It is not immediately apparent how *BHMT* would increase NTD risk in a folate-rich environment. In adults, BHMT functions predominantly in the liver, whereas MTR is active in all tissues ([@b41-ehp0114-001547]), but the expression patterns in the developing embryo are unknown and may be markedly different than that in the adult. BHMT is responsible for up to 50% of methylation in the adult liver ([@b8-ehp0114-001547]).

The methyl cycle supplies 1-carbon units critical for a variety of methylation reactions essential for proper gene expression and maternal and paternal imprinting by methylated DNA ([@b23-ehp0114-001547]). Growth factor genes are commonly imprinted in this manner, and nutrition can alter these methylation patterns ([@b37-ehp0114-001547]). Faulty embryonic methylation of DNA due to abnormal folate levels or improper methyl cycle gene expression at a critical developmental juncture could inappropriately silence growth factors necessary for proper tube closure.

Homocysteine levels are also maintained by the methyl cycle and play a role in NTD risk. Large-dose oral betaine therapy, a BHMT cofactor, treats hyperhomocysteinemia by shunting homocysteine through a betaine-dependent remethylation pathway ([@b13-ehp0114-001547]). When folate dependent methio-nine synthesis is impaired, by either genetic or environmental factors, BHMT plays a critical role in homocysteine homeostasis ([@b39-ehp0114-001547]). However, the *BHMT* R (G allele) and Q (A allele) proteins show no differences in thermostability or enzymatic Michaelis constant (Q = 2.7 and R = 2.8) ([@b39-ehp0114-001547]). The association of hyperhomocysteinemia with NTD risk implicates enzymes such as MTR, BHMT, and CBS that degrade homocysteine.

Our observed relationship between *BHMT*, folate supplementation, and NTD risk appears counterintuitive. It is possible that the stratification method inadvertently grouped families by an unidentified cofactor correlated with supplementation. The *BHMT* polymorphism could also create a highly efficient variant that causes the metabolic cycles to overfunction when combined with high folate levels. Human NTDs can only be studied at birth, not at the true point of incidence 28 days postconception, so we may fail to observe a high-risk group incompatible with life. Such individuals with insufficient BHMT and low folate may not be observable unless they also have an additional unknown protective factor. All these hypotheses are highly speculative, particularly in the absence of any biological support.

In the subset of families also transmitting the *MTHFR* T allele, affected children who have inherited at least one copy of the thermolabile allele from a heterozygous parent are even more likely to have also received the *BHMT* A allele. A gene--gene interaction between *MTHFR* and *BHMT* would require polymorphisms in both genes for the disorder, or additional correlated factors are involved and undetectable in this sample. These results implicate *BHMT* in NTD risk alone, in conjunction with maternal folate supplementation, and/or a polymorphism in *MTHFR* that proper folate metabolism.

Other folate pathway genes implicated
-------------------------------------

The most widely studied gene in NTD research, *MTHFR*, is not a significant risk factor in our overall data set. In families that did not receive folate supplementation, the rs1801133 polymorphism was moderately significant. Significant prior research combined *MTHFR* with other genes, and our results found *BHMT* to be highly significant in the T allele subgroup.

*MTHFR* rs1801133 is not the only genetic NTD risk factor, particularly in Caucasian Americans. Some NTD cases are not folic acid preventable, and at most 25% of cases can be solely explained by rs1801133 ([@b21-ehp0114-001547]; [@b36-ehp0114-001547]). Excluding TT genotype people, there is still a decrease in folate and increase in homocysteine levels in patients and their parents ([@b35-ehp0114-001547]).

Some previously investigated NTD-related genes included in this study are less likely to be involved because of their biochemical function. For example, FOLR2 is not the primary binder of folate, therefore the lack of significant association does not contradict models of folate metabolism ([@b33-ehp0114-001547]). Mathematical models of the folate and methionine cycles indicate that these systems are quite robust to dietary folate intake and perform well without significant folate intake for several months ([@b20-ehp0114-001547]).

Conversely, lack of significance does not rule out their involvement in the etiology of NTDs. Under a dominant model with a baseline risk of 0.0001 and a genetic relative risk of 0.6, 300 case--parent trios have a power of 0.62 to detect a main genetic effect at a 0.05 significance level. Some genes in our study may be involved in human NTDs but cannot be detected with our sample size. In addition, typing one nonsynonymous SNP in a gene cannot capture the complete genetic diversity. For key genes more thorough interrogation requires exonic, intronic, and regulatory SNPs. The HapMap provides tagging SNPs based on the LD structure of the genomic region ([@b3-ehp0114-001547]). Genes such as *MTR* are particularly problematic because high LD across a large region will make it very difficult to identify causative SNPs. Methionine cycle genes, such as *S*-adenosylhomocysteine hydrolase (*AHCY*; GenBank accession no. NM_000687), regulate the production of homocysteine and should also be investigated.

All SNPs were tested for HWE before analysis, primarily to identify genotyping errors. Of all the SNPs tested, only *MTHFD1* rs2236225 was out of HWE (*p* = 0.004) only in affected individuals. Departure from HWE in this study could result from genotyping error, selection, small sample size, or nonrandom mating. Unaffected individuals were in HWE for this SNP, potentially indicating an association, but no subsequent association was detected for this SNP. No other SNPs deviated from HWE, so there does not appear to be a widespread problem with the ascertainment of this sample set. Although this HWE deviation is interesting, it does not affect the overall outcome of the study because *MTHFD1* was not an implicated gene.

NTDs are a complex disorder involving many genetic and environmental factors. Future studies aimed at identifying these risk factors must approach the problem with a wide perspective including several genes and collecting as much environmental data as possible. Despite substantial efforts to associate NTDs with folate genes, there is no convincing evidence of an association for most of these genes. The role of folate in the etiology of NTDs could result from epigenetic effects or interactions with nonfolate genes. All previous research supports the multifactorial nature of NTDs underlining the necessity of multiple approaches in order to disentangle the contributors to this complex disorder.
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![The folate and methionine cycles highlighting the 11 genes included in this study. Substrates are shown in rectangular boxes; enzymes are shown in ellipses. Adapted from [@b20-ehp0114-001547] and [@b24-ehp0114-001547]. Substrate abbreviations: AdoHcy, *S*-adenosylhomocysteine; AdoMet, *S*-adenosylmethionine; DHF, dihydrofolate; 5,10-CH-THF, 5,10-methenyltetrahydrofolate; 5,10-CH2-THF, 5,10-methylenetetrahydrofo-late; THF, tetrahydrofolate; 5mTHF, 5-methyltetrahydrofolate; 10f-THF, 10-formyltetrahydrofolate. Enzyme abbreviations not included elsewhere: AICART, aminoimidazolecarboxamide ribotide transformylase; DHFR, dihydrofolate reductase; FTD, 10-formyltetrahydrofolate dehydrogenase; FTS, 10-formyltetrahydrofolate synthase; GNMT, glycine *N*-methyltransferase; MAT, methionine adenosyltransferase; meth, *S*-adenosylmethionine-dependent methyltransferases; MTCH, 5,10-methylenetetrahydrofolate cyclohydro-lase; NE, nonenzymatic interconversion of THF and 5,10-CH2-THF; PGT, phosphoribosyl glycinamidetrans-formylase; SAHH, *S*-adenosylhomocysteine hydrolase; TS, thymidylate synthase.](ehp0114-001547f1){#f1-ehp0114-001547}

![Genomic location of genotyped SNPs in relation to the three genes with three or more genotyped SNPs: *MTR*, *BHMT*, and *CBS*.](ehp0114-001547f2){#f2-ehp0114-001547}

###### 

Sample set details for the narrow (lumbo-sacral myelomeningocele only) and broad (any level NTD) diagnostic groups divided by maternal vitamin supplementation that was available for approximately 75% of mothers of affecteds.

  Data set                      Narrow   Broad
  ----------------------------- -------- -------
  Full data set                          
   Families                     279      304
   Affecteds                    297      332
   Samples                      1,158    1,259
  Folate before conception               
   Families                     69       76
   Affecteds                    75       85
   Samples                      307      330
  No folate before conception            
   Families                     141      149
   Affecteds                    151      165
   Samples                      617      653

###### 

SNPs genotyped in the data set.

  Gene symbol   Gene name                                                           GenBank accession no.   rs no.       Type of SNP
  ------------- ------------------------------------------------------------------- ----------------------- ------------ ---------------------------------------------------
  *FOLR1*       folate receptor 1                                                   NM_016725               rs2071010    Intronic
  *FOLR2*       folate receptor 2                                                   NM_000803               rs2298444    Intronic
  *SLC19A1*     solute carrier family 19 member 1                                   U15939                  rs1051266    Nonsynonymous
  *TCN2*        transcobalamin II                                                   NM_000355               rs1801198    Nonsynonymous
  *MTHFD1*      methylenetetrahydrofolate dehydrogenase 1                           J04031                  rs2236225    Nonsynonymous
  *SHMT1*       serine hydroxyl-methyltranferase 1                                  NM_004169               rs1979277    Nonsynonymous
  *MTHFR*       5,10 methylene-tetrahydrofolate reductase                           NM_005957               rs1801133    Nonsynonymous
                                                                                                            rs1801131    Nonsynonymous
  *MTR*         5-methyltetrahydrofolate-homocysteine methyltransferase             NM_000254               rs10925235   Intronic
                                                                                                            rs12060570   Intronic
                                                                                                            rs10925250   Intronic
                                                                                                            rs1805087    Nonsynonymous
                                                                                                            rs4659743    intronic
  *MTRR*        5-methyltetrahydrofolate-homocysteine methyltransferase reductase   AF025794                rs1801394    Nonsynonymous
  *BHMT*        betaine-homocysteine methyltransferase                              BC012616                rs651852     Intronic
                                                                                                            rs7700970    Intronic
                                                                                                            rs3733890    Nonsynonymous
                                                                                                            rs558133     Intronic
  *CBS*         cystathionine-beta-synthase                                         NM_000071               rs234783     Intergenic
                                                                                                            rs234715     Intronic
                                                                                                            rs2851391    Intronic
                                                                                                            844ins68     ---[a](#tfn2-ehp0114-001547){ref-type="table-fn"}
                                                                                                            rs1789953    Intronic
                                                                                                            rs4920037    Intronic
                                                                                                            rs1801181    Synonymous
                                                                                                            rs9325622    Intronic
                                                                                                            rs12613      Intronic
                                                                                                            rs412810     Intergenic

Gene annotations are from GenBank (<http://www.ncbi.nih.gov/GenBank>).

844ins68 is a 68-bp insertion in exon 8 of *CBS*.

###### 

Single-gene *p*-values from significant association tests with an environmental stratum.

                            Narrow                                                 Broad                                                                                                         
  --------- --------------- ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------------------
  *BHMT*    rs3733890                                                                                                                                                                            
            Full data set   0.023[\*](#tfn4-ehp0114-001547){ref-type="table-fn"}   0.058                                                  0.025[\*](#tfn4-ehp0114-001547){ref-type="table-fn"}   0.035[\*](#tfn4-ehp0114-001547){ref-type="table-fn"}
            No suppl.       0.357                                                  0.635                                                  0.245                                                  0.390
            Yes suppl.      0.027[\*](#tfn4-ehp0114-001547){ref-type="table-fn"}   0.055                                                  0.016[\*](#tfn4-ehp0114-001547){ref-type="table-fn"}   0.027[\*](#tfn4-ehp0114-001547){ref-type="table-fn"}
  *BHMT*    rs558133                                                                                                                                                                             
            Full data set   0.114                                                  0.124                                                  0.026[\*](#tfn4-ehp0114-001547){ref-type="table-fn"}   0.061
            No suppl.       0.765                                                  0.983                                                  0.296                                                  0.657
            Yes suppl.      0.036[\*](#tfn4-ehp0114-001547){ref-type="table-fn"}   0.139                                                  0.012[\*](#tfn4-ehp0114-001547){ref-type="table-fn"}   0.097
  *MTHFR*   rs1801133                                                                                                                                                                            
            Full data set   0.203                                                  0.112                                                  0.317                                                  0.263
            No suppl.       0.153                                                  0.046[\*](#tfn4-ehp0114-001547){ref-type="table-fn"}   0.235                                                  0.102
            Yes suppl.      0.529                                                  0.910                                                  0.906                                                  0.657
  *MTR*     rs10925235                                                                                                                                                                           
            Full data set   0.877                                                  0.794                                                  0.715                                                  0.865
            No suppl.       0.066                                                  0.031[\*](#tfn4-ehp0114-001547){ref-type="table-fn"}   0.040[\*](#tfn4-ehp0114-001547){ref-type="table-fn"}   0.027[\*](#tfn4-ehp0114-001547){ref-type="table-fn"}
            Yes suppl.      0.456                                                  0.444                                                  0.789                                                  0.686
  *MTR*     rs4659743                                                                                                                                                                            
            Full data set   0.885                                                  0.426                                                  0.547                                                  0.375
            No suppl.       0.104                                                  0.013[\*](#tfn4-ehp0114-001547){ref-type="table-fn"}   0.041[\*](#tfn4-ehp0114-001547){ref-type="table-fn"}   0.010[\*](#tfn4-ehp0114-001547){ref-type="table-fn"}
            Yes suppl.      0.891                                                  0.972                                                  0.553                                                  0.741
  *CBS*     rs234715                                                                                                                                                                             
            Full data set   0.287                                                  0.617                                                  0.160                                                  0.328
            No suppl.       0.056                                                  0.190                                                  0.015[\*](#tfn4-ehp0114-001547){ref-type="table-fn"}   0.064
            Yes suppl.      0.527                                                  0.562                                                  0.435                                                  0.683
  *CBS*     rs4920037                                                                                                                                                                            
            Full data set   0.514                                                  0.787                                                  0.277                                                  0.525
            No suppl.       0.122                                                  0.213                                                  0.037[\*](#tfn4-ehp0114-001547){ref-type="table-fn"}   0.085
            Yes suppl.      0.423                                                  0.509                                                  0.435                                                  0.650

Suppl., supplementation with folic acid before conception.

*p* \< 0.05.

###### 

Linkage disequilibrium (*D*′ and *r*^2^) between SNPs in genes where more than three SNPs were genotyped in affected individuals.

  *MTR*        rs10925235                                             rs12060570                                             rs10925250                                             rs1805087                                              rs4659743
  ------------ ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------------------
  rs10925235                                                          0.966[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}   0.9                                                    0.953[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}   0.973[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}
  rs12060570   0.379                                                                                                         0.962[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}   0.961[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}   0.949[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}
  rs10925250   0.122                                                  0.176                                                  1[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}       0.91[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}    
  rs1805087    0.131                                                  0.169                                                  0.976[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}                                                          0.958[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}
  rs4659743    0.946[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}   0.36                                                   0.127                                                  0.137                                                  

  *BHMT*      rs651852   rs7700970   rs3733890   rs558133
  ----------- ---------- ----------- ----------- --------------------------------------------------
  rs651852               0.884       0.632       0.226
  rs7700970   0.316                  0.367       0.334
  rs3733890   0.14       0.124                   1[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}
  rs558133    0.028      0.02        0.162       

  *CBS*       rs234783   rs234715                                              rs2851391                                              844ins68                                           rs1789953                                              rs4920037                                              rs1801181                                              rs9325622                                              rs12613                                                rs412810
  ----------- ---------- ----------------------------------------------------- ------------------------------------------------------ -------------------------------------------------- ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------------------ ----------
  rs234783               0.708                                                 0.786                                                  0.019                                              0.868                                                  0.69                                                   0.86                                                   0.841                                                  0.111                                                  0.524
  rs234715    0.192                                                            0.963[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}   1[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}   1[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}       1[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}       1[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}       1[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}       1[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}       0.791
  rs2851391   0.579      0.383                                                                                                        1[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}   0.915[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}   0.964[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}   0.985[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}   0.986[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}   1[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}       0.781
  844ins68    0          0.028                                                 0.068                                                                                                     1[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}       1[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}       0.897                                                  0.789                                                  0.971[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}   0.727
  rs1789953   0.13       0.048                                                 0.152                                                  0.012                                                                                                     1[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}       1[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}       1[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}       0.999[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}   0.694
  rs4920037   0.183      0.98[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}   0.395                                                  0.028                                              0.049                                                                                                         1[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}       1[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}       1[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}       0.802
  rs1801181   0.413      0.21                                                  0.487                                                  0.045                                              0.096                                                  0.213                                                                                                         0.975[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}   1[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}       0.79
  rs9325622   0.392      0.214                                                 0.494                                                  0.037                                              0.094                                                  0.214                                                  0.934[\*](#tfn6-ehp0114-001547){ref-type="table-fn"}                                                          0.883                                                  0.803
  rs12613     0.001      0.026                                                 0.064                                                  0.846                                              0.012                                                  0.026                                                  0.055                                                  0.043                                                                                                         0.681
  rs412810    0.149      0.441                                                 0.372                                                  0.02                                               0.032                                                  0.456                                                  0.185                                                  0.201                                                  0.017                                                  

*D'* values are given above the diagonal; *r* ^2^ values are given below the diagonal.

Linkage disequilibrium \> 0.9.

###### 

Single-gene *p*-values from significant association tests when stratified by preferential transmission of BHMT rs3733890 alleles.

  Gene       SNP         Narrow                                                 Broad                                                                                                         
  ---------- ----------- ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------------------
  *SHMT1*    rs1979277                                                                                                                                                                        
             G allele    0.157                                                  0.042[\*](#tfn7-ehp0114-001547){ref-type="table-fn"}   0.066                                                  0.020[\*](#tfn7-ehp0114-001547){ref-type="table-fn"}
             A allele    0.096                                                  0.204                                                  0.101                                                  0.247
             Neither     0.448                                                  0.522                                                  0.463                                                  0.699
  *MTR*      rs4659743                                                                                                                                                                        
             G allele    0.185                                                  0.049[\*](#tfn7-ehp0114-001547){ref-type="table-fn"}   0.052                                                  0.015[\*](#tfn7-ehp0114-001547){ref-type="table-fn"}
             A allele    0.691                                                  0.184                                                  0.701                                                  0.193
             Neither     0.134                                                  0.146                                                  0.169                                                  0.104
  *CBS*      844ins68                                                                                                                                                                         
             G allele    0.033[\*](#tfn7-ehp0114-001547){ref-type="table-fn"}   0.222                                                  0.033[\*](#tfn7-ehp0114-001547){ref-type="table-fn"}   0.217
             A allele    0.248                                                  0.287                                                  0.285                                                  0.473
             Neither     0.842                                                  0.318                                                  1.000                                                  0.560
  *MTHFD1*   rs2236225                                                                                                                                                                        
             G allele    0.701                                                  0.407                                                  0.392                                                  0.225
             A allele    0.064                                                  0.214                                                  0.016[\*](#tfn7-ehp0114-001547){ref-type="table-fn"}   0.093
             Neither     0.822                                                  0.666                                                  0.915                                                  0.739

*p* \< 0.05.

###### 

Single-gene *p*-values from significant association tests when stratified by preferential transmission of MTHFR rs1801133 alleles.

  Gene      SNP         Narrow                                                 Broad                                                                                                         
  --------- ----------- ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------------------
  *BHMT*    rs3733890                                                                                                                                                                        
            C allele    0.647                                                  0.815                                                  0.405                                                  0.991
            T allele    0.007[\*](#tfn8-ehp0114-001547){ref-type="table-fn"}   0.027[\*](#tfn8-ehp0114-001547){ref-type="table-fn"}   0.010[\*](#tfn8-ehp0114-001547){ref-type="table-fn"}   0.047[\*](#tfn8-ehp0114-001547){ref-type="table-fn"}
            Neither     0.335                                                  0.171                                                  0.463                                                  0.143
  *TCN2*    rs1801198                                                                                                                                                                        
            C allele    1.000                                                  0.661                                                  0.814                                                  0.507
            T allele    0.056                                                  0.092                                                  0.045[\*](#tfn8-ehp0114-001547){ref-type="table-fn"}   0.073
            Neither     0.829                                                  0.959                                                  1.000                                                  0.932
  *MTRR*    rs1801394                                                                                                                                                                        
            C allele    0.109                                                  0.050                                                  0.099                                                  0.048[\*](#tfn8-ehp0114-001547){ref-type="table-fn"}
            T allele    0.439                                                  0.465                                                  0.904                                                  0.805
            Neither     0.473                                                  0.601                                                  0.502                                                  0.717
  *SHMT1*   rs1979277                                                                                                                                                                        
            C allele    0.317                                                  0.370                                                  0.279                                                  0.318
            T allele    0.475                                                  0.547                                                  0.249                                                  0.295
            Neither     0.050[\*](#tfn8-ehp0114-001547){ref-type="table-fn"}   0.193                                                  0.037[\*](#tfn8-ehp0114-001547){ref-type="table-fn"}   0.190

*p*\< 0.05.
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